STACY MARRIOTT: Open Payments
NPI 1255981528 · ALTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 16 payments from 9 companies in 2025. Trend: 2023 $169 · 2024 $595 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $196 |
| Lilly USA, LLC | 4 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Novo Nordisk Inc | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: AIRSUPRA, MOUNJARO, JARDIANCE, FARXIGA, Ozempic, REXULTI, GEMTESA, LINZESS.
Industry payments across IL — which companies pay providers there.
